The precautionary principle demands that we err on the side of caution when there are unknown risks for a given medical product. This is especially true for pregnant and breastfeeding women who must consider not only themselves, but the impact on their developing fetus or child.
An international panel of pregnancy, birthing and breastfeeding experts join together to create resources to empower pregnant and breastfeeding women to make informed choices.
The following resources are prepared by CCCA and Mama Bears Project.
In this short video, women are encouraged to be more critical in assessing their need for vaccines during pregnancy and while breastfeeding by asking for evidence that safety has been proven, that the product is indeed necessary, and if its claimed benefits have actually been proven.
This resource guide is the collaborative effort of the CCCA and international experts in the fields of pregnancy, birthing, and breastfeeding. This document uses evidence-based research to frame the ethical and medical considerations of the use of undertested medical products during pregnancy and breastfeeding. History has taught us that the precautionary principle must always be used when using medical interventions during these vulnerable periods.
Use this shareable infographic to encourage pregnant and breastfeeding mothers to ask questions about medical products they may be recommended to use. The mRNA products have not been proven safe for this group, and without appropriate safety data, mothers and mothers-to-be cannot make knowledgeable informed choices. The QR code directs the reader to our campaign home page.
RSV Vaccination and the Pharma Playbook
A fundamental tenet of health care is – “First, do no harm”. This principle must never be compromised when caring for pregnant mothers. To minimize probable harmful exposure and consequences to the mom and baby, women have been encouraged to avoid medications during pregnancy. It is an ethical and moral imperative that drugs administered during pregnancy must have an established safety record and be of proven therapeutic value. This article, written by members of the CCCA’s Scientific and Medical Advisory Committee (SMAC), reviews the tactics used by the pharmaceutical industry to increase the chances of vaccine approval and uptake by pregnant women for the RSV vaccine. An awareness of such promotional strategies allows mothers and healthcare providers to critically assess the need for therapeutic products being promoted during pregnancy and breastfeeding.
Search
Top Categories
WANT TO BECOME A MEMBER?
To learn more about how you can join the Canadian Covid Care Alliance click the link below.
Popular Posts
Stay Connected
